2INV Stock Overview
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
2invest AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €10.40 |
| 52 Week High | €10.70 |
| 52 Week Low | €5.55 |
| Beta | 0.33 |
| 11 Month Change | -1.89% |
| 3 Month Change | 13.66% |
| 1 Year Change | 48.57% |
| 33 Year Change | -19.38% |
| 5 Year Change | 13.29% |
| Change since IPO | -68.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2INV | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -1.0% | -1.2% | 0.2% |
| 1Y | 48.6% | -16.1% | 7.6% |
Return vs Industry: 2INV exceeded the German Biotechs industry which returned -16.1% over the past year.
Return vs Market: 2INV exceeded the German Market which returned 7.6% over the past year.
Price Volatility
| 2INV volatility | |
|---|---|
| 2INV Average Weekly Movement | 2.8% |
| Biotechs Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2INV has not had significant price volatility in the past 3 months.
Volatility Over Time: 2INV's weekly volatility has decreased from 8% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 5 | n/a | 2invest-ag.com |
2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG is based in Heidelberg, Germany.
2invest AG Fundamentals Summary
| 2INV fundamental statistics | |
|---|---|
| Market cap | €59.78m |
| Earnings (TTM) | €5.03m |
| Revenue (TTM) | €7.74m |
11.9x
P/E Ratio7.7x
P/S RatioIs 2INV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2INV income statement (TTM) | |
|---|---|
| Revenue | €7.74m |
| Cost of Revenue | €0 |
| Gross Profit | €7.74m |
| Other Expenses | €2.71m |
| Earnings | €5.03m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 100.00% |
| Net Profit Margin | 64.99% |
| Debt/Equity Ratio | 0% |
How did 2INV perform over the long term?
See historical performance and comparison